Wilhelmus F Leemans

Learn More
BACKGROUND AND OBJECTIVE Entecavir has potent activity against hepatitis B virus. Drug resistance has not been reported in nucleoside-naïve patients and is low in lamivudine-refractory patients. (More)
BACKGROUND/AIMS To determine the response to pegylated interferon-alpha treatment of HBeAg-positive hepatitis B patients with proven lamivudine resistance. METHODS Sixteen HBeAg-positive HBV(More)
  • 1